Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
出版年份 2023 全文链接
标题
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 129, Issue 8, Pages 1212-1224
出版商
Springer Science and Business Media LLC
发表日期
2023-07-16
DOI
10.1038/s41416-023-02361-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting TBK1 to overcome resistance to cancer immunotherapy
- (2023) Yi Sun et al. NATURE
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2023) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities
- (2023) Maisoon Matareed et al. JOURNAL OF PATHOLOGY
- Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas
- (2023) Mona Meng Wang et al. Frontiers in Immunology
- Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
- (2023) Jie Yin et al. Pharmaceuticals
- Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
- (2022) Zaoqu Liu et al. Nature Communications
- Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling
- (2022) John J. Park et al. CANCER GENE THERAPY
- Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review
- (2022) Szonja Anna Kovács et al. Journal of Translational Medicine
- A vaccine targeting resistant tumours by dual T cell plus NK cell attack
- (2022) Soumya Badrinath et al. NATURE
- Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
- (2022) Brandie C. Taylor et al. Frontiers in Immunology
- Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer
- (2022) Zengqing Guo et al. npj Precision Oncology
- Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
- (2022) Chunmei Fu et al. IMMUNOLOGICAL INVESTIGATIONS
- Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma
- (2022) Samuel Coleman et al. MOLECULAR CARCINOGENESIS
- Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
- (2022) Silvia D’Amico et al. Frontiers in Immunology
- The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
- (2022) Lina S. Farhoumand et al. Cancers
- Tebentafusp for the treatment of HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma
- (2022) Lanyi Nora Chen et al. Expert Review of Anticancer Therapy
- Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
- (2022) Richard D. Carvajal et al. NATURE MEDICINE
- Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
- (2022) Shaheer Khan et al. Frontiers in Oncology
- Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis
- (2022) James Draper et al. CURRENT EYE RESEARCH
- Non-viral precision T cell receptor replacement for personalized cell therapy
- (2022) Susan P. Foy et al. NATURE
- Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
- (2021) Mona Meng Wang et al. Frontiers in Molecular Biosciences
- Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
- (2021) Hisashi Uhara et al. JOURNAL OF DERMATOLOGY
- The Next Decade of Immune Checkpoint Therapy
- (2021) Padmanee Sharma et al. Cancer Discovery
- Enhancing programmed cell death protein 1 axis inhibition in head and neck squamous cell carcinoma: Combination immunotherapy
- (2021) Ioannis A. Vathiotis et al. CANCER TREATMENT REVIEWS
- Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: Results from a phase I/II clinical trial
- (2021) Reetta Virtakoivu et al. CLINICAL CANCER RESEARCH
- Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
- (2021) Paul Nathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tebentafusp for uveal melanoma
- (2021) David Killock Nature Reviews Clinical Oncology
- Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?
- (2021) Chiara L. Blomen et al. Cancers
- A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma
- (2021) Alexander N. Shoushtari et al. Cancers
- NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
- (2020) Kirsty Ford et al. CANCER RESEARCH
- Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
- (2020) Carlos R. Figueiredo et al. JOURNAL OF PATHOLOGY
- Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region
- (2020) Sarah E. Coupland et al. JAMA Ophthalmology
- Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells
- (2020) Fabrício C. Machado et al. Frontiers in Immunology
- A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors
- (2020) Agata Mlynska et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma
- (2020) Sophie Thornton et al. Cancers
- New tools to prevent cancer growth and spread: a ‘Clever’ approach
- (2020) Maija Hollmén et al. BRITISH JOURNAL OF CANCER
- A Phase 2 Study of Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
- (2020) Annie A. Wu et al. CLINICAL CANCER RESEARCH
- Dendritic cell therapy in cancer treatment; the state-of-the-art
- (2020) Mahsa Sadeghzadeh et al. LIFE SCIENCES
- Antitumour dendritic cell vaccination in a priming and boosting approach
- (2020) Alexandre Harari et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture
- (2020) Karen Aughton et al. Translational Vision Science & Technology
- T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
- (2020) Christopher J. Hanley et al. BRITISH JOURNAL OF CANCER
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
- (2020) Vincent Chau et al. Cancer Management and Research
- Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections
- (2020) Hongrun Zhang et al. Translational Vision Science & Technology
- MIF-Dependent Control of Tumor Immunity
- (2020) Jordan T. Noe et al. Frontiers in Immunology
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T Cell Response Against Immunosuppressive Tumors
- (2019) Miro K Viitala et al. CLINICAL CANCER RESEARCH
- Single-cell-MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis
- (2019) Wei Jian Tan et al. BLOOD
- Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
- (2019) Paola Queirolo et al. SEMINARS IN CANCER BIOLOGY
- Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
- (2019) Jonathan A. Trujillo et al. Journal for ImmunoTherapy of Cancer
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
- (2018) Guang-Tao Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interleukin-10 Directly Inhibits CD8 + T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity
- (2018) Logan K. Smith et al. IMMUNITY
- TGF-β Inhibition and Immunotherapy: Checkmate
- (2018) Karuna Ganesh et al. IMMUNITY
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- The molecular basis of JAK/STAT inhibition by SOCS1
- (2018) Nicholas P. D. Liau et al. Nature Communications
- Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
- (2018) Rajani Ravi et al. Nature Communications
- Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
- (2018) Carlos R. Figueiredo et al. Frontiers in Immunology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level RORγt Expression
- (2018) Bofeng Li et al. JOURNAL OF IMMUNOLOGY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
- (2018) Elise Ramia et al. OncoImmunology
- Adipophilin expression in primary and metastatic uveal melanoma: a pilot study
- (2017) Miltiadis Fiorentzis et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
- (2017) Smita S Chandran et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
- (2017) Jiehui Deng et al. Cancer Discovery
- Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells
- (2017) Xing Guo et al. Oncotarget
- IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
- (2016) Yosuke Ohno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- TCR Signal Strength Alters T–DC Activation and Interaction Times and Directs the Outcome of Differentiation
- (2016) Nicholas van Panhuys Frontiers in Immunology
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo
- (2015) Carlos R. Figueiredo et al. Scientific Reports
- Two Distinct Uveal Melanomas in the Same Eye
- (2015) Ebba J. Nissen et al. JAMA Ophthalmology
- Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
- (2014) H Kalirai et al. BRITISH JOURNAL OF CANCER
- Clever-1/Stabilin-1 Controls Cancer Growth and Metastasis
- (2014) M. Karikoski et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells
- (2014) Shasha Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes
- (2014) Pierre L Triozzi et al. OncoImmunology
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
- (2013) J. Tel et al. CANCER RESEARCH
- Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation
- (2013) Bryan Vander Lugt et al. NATURE IMMUNOLOGY
- Human phagosome processing of Mycobacterium tuberculosisantigens is modulated by interferon-γ and interleukin-10
- (2012) Karen Bobadilla et al. IMMUNOLOGY
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- (2011) An M. T. Van Nuffel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment
- (2010) David Simons et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN- -induced MHC class II molecule on primary human blood macrophages
- (2010) L. L. Y. Chan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The MIF Homologue D-Dopachrome Tautomerase Promotes COX-2 Expression through -Catenin-Dependent and -Independent Mechanisms
- (2010) D. Xin et al. MOLECULAR CANCER RESEARCH
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- Macrophages: Master Regulators of Inflammation and Fibrosis
- (2010) Thomas Wynn et al. SEMINARS IN LIVER DISEASE
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
- (2008) M Campoli et al. ONCOGENE
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started